ACU-D1

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameACU-D1
Drug Alias NameACU-D1ACUD1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsAnal intraepithelial neoplasiaSquamous Intraepithelial LesionsRosacea +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAccuitis Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmory University
Inactive CompaniesAccuitis Inc
Active IndicationsAnal intraepithelial neoplasiaSquamous Intraepithelial LesionsPapillomavirus Infections +[4] 
Inactive IndicationsRosacea

Other Information

ATC CodeN/A
Related LinksN/A